Paper36770940
Identification of a Novel Angiogenesis Signalling circSCRG1/miR-1268b/NR4A1 Pathway in Atherosclerosis and the Regulatory Effects of TMP-PF In Vitro.
Yuan R and 6 others. Molecules, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Identification of a Novel Angiogenesis Signalling circSCRG1/miR-1268b/NR4A1 Pathway in Atherosclerosis and the Regulatory Effects of TMP-PF In Vitro. Papers, record 36770940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770940
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of a Novel Angiogenesis Signalling circSCRG1/miR-1268b/NR4A1 Pathway in Atherosclerosis and the Regulatory Effects of TMP-PF In Vitro.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| MicroRNAs | Major topic |
| Nuclear Receptor Subfamily 4, Group A, Member 1 | Major topic |
| Plaque, Atherosclerotic | Major topic |
| RNA, Circular | Major topic |
| Humans | |
| Apoptosis | |
| Cell Proliferation | |
| Human Umbilical Vein Endothelial Cells | |
| Lipoproteins, LDL | |
| Glycosides | |
| Pyrazines | |
| Nerve Tissue Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZZ11-061, ZZ14-YQ-007 | Fundamental Research Funds for the Central public welfare research institutes | PubMed | ||
| 82004193 | National Natural Science Foundation of China | PubMed | ||
| CI 2021A00914 | China Academy of Chinese Medical Sciences (CACMS) Innovation Fund | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35584701 | Circular RNAs: Characterization, cellular roles, and applications. | Cell | 2022 | https://conductscience.org/library/papers/35584701 | PubMed |
| 2 | 30952956 | Circular RNAs open a new chapter in cardiovascular biology. | Nat Rev Cardiol | 2019 | https://conductscience.org/library/papers/30952956 | PubMed |
| 3 | 32304667 | Engineered Circular RNA Sponges Act as miRNA Inhibitors to Attenuate Pressure Overload-Induced Cardiac Hypertrophy. | Mol Ther | 2020 | https://conductscience.org/library/papers/32304667 | PubMed |
| 4 | 31654655 | Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells. | Microvasc Res | 2020 | https://conductscience.org/library/papers/31654655 | PubMed |
| 5 | 30735634 | Widespread and Functional RNA Circularization in Localized Prostate Cancer. | Cell | 2019 | https://conductscience.org/library/papers/30735634 | PubMed |
| 6 | 34935184 | Circular RNA circUSP13 sponges miR-29c to promote differentiation and inhibit apoptosis of goat myoblasts by targeting IGF1. | FASEB J | 2022 | https://conductscience.org/library/papers/34935184 | PubMed |
| 7 | 30993566 | Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma. | Angiogenesis | 2019 | https://conductscience.org/library/papers/30993566 | PubMed |
| 8 | 34750830 | Silencing of circARHGAP12 inhibits the progression of atherosclerosis via miR-630/EZH2/TIMP2 signal axis. | J Cell Physiol | 2022 | https://conductscience.org/library/papers/34750830 | PubMed |
| 9 | 33649864 | circRNA‑0006896‑miR1264‑DNMT1 axis plays an important role in carotid plaque destabilization by regulating the behavior of endothelial cells in atherosclerosis. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33649864 | PubMed |
| 10 | 28055275 | The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases. | Expert Opin Ther Targets | 2017 | https://conductscience.org/library/papers/28055275 | PubMed |
| 11 | 35169296 | Specific expression and functions of circular RNAs. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/35169296 | PubMed |
| 12 | 9797341 | Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. | Circ Res | 1998 | https://conductscience.org/library/papers/9797341 | PubMed |
| 13 | 35483189 | Tetramethylpyrazine: A review on its mechanisms and functions. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35483189 | PubMed |
| 14 | 31626900 | Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. | Genomics | 2020 | https://conductscience.org/library/papers/31626900 | PubMed |
| 15 | 33207953 | Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation. | Circulation | 2021 | https://conductscience.org/library/papers/33207953 | PubMed |
| 16 | 33634114 | Targeting NR4A Nuclear Receptors to Control Stromal Cell Inflammation, Metabolism, Angiogenesis, and Tumorigenesis. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33634114 | PubMed |
| 17 | 32682112 | A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/32682112 | PubMed |
| 18 | 33141028 | Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33141028 | PubMed |
| 19 | 32968666 | Insight from imaging on plaque vulnerability: similarities and differences between coronary and carotid arteries-implications for systemic therapies. | Cardiovasc Diagn Ther | 2020 | https://conductscience.org/library/papers/32968666 | PubMed |
| 20 | 30584451 | Tetramethylpyrazine and Paeoniflorin Inhibit Oxidized LDL-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells via VEGF and Notch Pathways. | Evid Based Complement Alternat Med | 2018 | https://conductscience.org/library/papers/30584451 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42528974 | Ligusticum chuanxiong and Paeonia lactiflora : a review of their regulation of iron metabolism and ferroptosis in atherosclerosis therapy. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42528974 | PubMed |
| 42313317 | Mechanisms ofra Tetmethylpyrazine in spinal cord injury: a narrative review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42313317 | PubMed |
| 41136358 | Harnessing miRNA therapeutics: a novel approach to combat heart and brain infarctions in atherosclerosis. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41136358 | PubMed |
| 39296643 | MiR-6721-5p as a natural regulator of Meta-VCL is upregulated in the serum of patients with coronary artery disease. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39296643 | PubMed |
| 39199340 | Circular RNA in Cardiovascular Diseases: Biogenesis, Function and Application. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199340 | PubMed |
| 38277288 | CircLZIC regulates ox-LDL-induced HUVEC cell proliferation and apoptosis via Micro-330-5p/NOTCH2 axis in atherosclerosis. | Clin Hemorheol Microcirc | 2024 | https://conductscience.org/library/papers/38277288 | PubMed |
| 37719883 | Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37719883 | PubMed |
| 37623241 | Circular RNAs Variously Participate in Coronary Atherogenesis. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37623241 | PubMed |
| 37240358 | Candidate SNP Markers Significantly Altering the Affinity of TATA-Binding Protein for the Promoters of Human Hub Genes for Atherogenesis, Atherosclerosis and Atheroprotection. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240358 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36770940
GET https://conductscience.org/api/papers/v1/36770940/references?page=2